CLINICAL_TRIALS
trial_result
· 2011-01-04
Clinical Trial Update: ISIS 2503 in Treating Patients With Advanced Cancer of the Pancreas [Phase 2]
Summary
This document provides an update on a Phase 2 clinical trial of ISIS 2503 in patients with advanced pancreatic cancer.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Alabama at Birmingham | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED